Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies

Research Tree Logo

  • Features
  • Pricing
  • RNS/News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
  • Features
  • Pricing
  • RNS/News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      UK Rest of EMEA N America APAC LatAm
    • Sectors
      Automobile Industry Banks Building & Construction Chemicals Discretionary Personal Goods Discretionary Retail Energy Financial Services Food & Drink Food Production Health Household Goods & DIY Industrial Equipment, Goods & Services Insurance & Reinsurance Leisure, Tourism & Travel Media Other Real Estate Resources Staple Retail Technology Telecoms Trusts, ETFs & Funds Utilities
    • Small / Large Cap
      UK100 UK250 UK Smallcap UK Other Main Markets Other
    • Private/EIS
      EIS Single Company EIS/SEIS Funds IHT Products SEIS Single Company VCT Funds
  • Providers
    • Free/Commissioned
      Align Research BRR Media Capital Access Research Edison Equity Development Fidante Partners Five Minute Pitch TV goetzpartners securities Limited Hardman & Co Independent Investment Research Kepler | Trust Intelligence piworld.co.uk Proactive Investors Progressive Equity Research QuotedData Radnor Capital Partners Research Tree Trinity Delta
    • High Net Worth Offering
      Allenby Capital AlphaValue Arden Partners Cenkos Securities finnCap GMP FirstEnergy Hybridan Liberum Louis Capital Marten & Co Medley Global Advisors N+1 Singer Northland Capital Partners SP Angel Stockdale Securities VSA Capital WHIreland Whitman Howard Zeus Capital
    • Institutional Offering
      Align Research Allenby Capital AlphaValue Arden Partners BRR Media Capital Access Research Cenkos Securities Edison Equity Development Fidante Partners finnCap Five Minute Pitch TV GMP FirstEnergy goetzpartners securities Limited Hardman & Co Hybridan Independent Investment Research Kepler | Absolute Hedge Kepler | Trust Intelligence Liberum N+1 Singer Northland Capital Partners piworld.co.uk Proactive Investors Progressive Equity Research QuotedData Radnor Capital Partners Research Tree SP Angel Stockdale Securities Trinity Delta VSA Capital WHIreland Whitman Howard Zeus Capital
    • Video/Audio Interviews
      BRR Media Edison Equity Development Five Minute Pitch TV piworld.co.uk Proactive Investors Research Tree
  • Contact
Research >
Elbit Medical Technologies - Another FDA approval and a US IPO

  • 06 Dec 2018

Elbit Medical Technologies - Another FDA approval and a US IPO

  • Edison
    • Maxim Jacobs

    • 6 pages

Stock Image



 
Stock Image



Elbit Medical Technologies’ two portfolio investments continue to advance. Notably, Gamida Cell announced a $53m IPO on Nasdaq in late October and presented NiCord data at the American Society of Hematology (ASH) annual meeting in December. InSightec reported record revenues for Q318 and received FDA approval for ExAblate Neuro compatibility with Siemens’ magnetic resonance (MR) scanners.


InSightec (~22% owned by Elbit Medical, ~18.5% fully diluted) recently announced its Q318 results. Revenues, which are based on the sale of ExAblate systems and corresponding annual service contract costs and consumables, were $8.1m, up 105% from Q217 ($4.0m). Notably, InSightec announced that it had received FDA approval for ExAblate Neuro compatibility with Siemens’ MR scanners. We expect this will provide InSightec with the opportunity to expand its presence in the global MR market.


Gamida Cell recently announced a $53m IPO on Nasdaq under the symbol GMDA, for 6.25m ordinary shares at $8.00 per share. Following this offering, Elbit Medical now owns ~11% of the company (previously ~18%). Gamida Cell also presented an update regarding its Phase I/II of NiCord as a graft evaluating immune reconstitution (IR) after myeloablative chemotherapy versus non-manipulated cord blood and traditional unrelated bone marrow transplant at ASH.


On 6 September, Elbit Imaging sold approximately 5% of Elbit Medical’s outstanding share capital to Exigent Capital Group for NIS11.1m. Two months later, Elbit Imaging sold an additional 10% of Elbit Medical’s outstanding share capital to the group for NIS21.3m. According to reports from 21 November and 28 November, Elbit Imaging sold an additional 8% and 3% of Elbit Medical’s outstanding share capital for NIS18.6m and NIS6.7m, respectively. Following these transactions, Elbit Imaging now owns ~63% of Elbit Medical (previously ~89%). The proceeds from these transactions will be used to repay their debts. 


We are decreasing our valuation to NIS424m NIS1.83 per share from NIS444.4m or NIS1.92 per share, which was mainly driven by the decrease in value of Elbit Medical’s stake in Gamida Cell following the IPO and offset by the increase in strength of the US dollar (NIS3.69/US$). We expect to update our valuation with the announcement of new deals and as the portfolio companies advance through the clinical pipeline.


Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

Assura - Half Year Results 2018

Companies: Assura

BRR Media

AEX Gold - Change in strategy driven by high nugget effect

Edison

Amerisur Resources - CPO-5 update

Companies: Amerisur Resources

BRR Media

Bushveld Minerals - Interview at 121 Mining, Cape Town

Companies: Bushveld Minerals

BRR Media

121 Mining, Cape Town - W Resources - Presentation

Companies: W Resources

BRR Media

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Heap | Mobile and Web Analytics

Copyright © 2019 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top
  • Home
  • Features
  • Pricing
  • RNS/News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Leisure, Tourism & Travel
      • Media
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Align Research
      • BRR Media
      • Capital Access Research
      • Edison
      • Equity Development
      • Fidante Partners
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Independent Investment Research
      • Kepler | Trust Intelligence
      • piworld.co.uk
      • Proactive Investors
      • Progressive Equity Research
      • QuotedData
      • Radnor Capital Partners
      • Research Tree
      • Trinity Delta
    • High Net Worth Offering
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • Cenkos Securities
      • finnCap
      • GMP FirstEnergy
      • Hybridan
      • Liberum
      • Louis Capital
      • Marten & Co
      • Medley Global Advisors
      • N+1 Singer
      • Northland Capital Partners
      • SP Angel
      • Stockdale Securities
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Zeus Capital
    • Institutional Offering
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Arden Partners
      • BRR Media
      • Capital Access Research
      • Cenkos Securities
      • Edison
      • Equity Development
      • Fidante Partners
      • finnCap
      • Five Minute Pitch TV
      • GMP FirstEnergy
      • goetzpartners securities Limited
      • Hardman & Co
      • Hybridan
      • Independent Investment Research
      • Kepler | Absolute Hedge
      • Kepler | Trust Intelligence
      • Liberum
      • N+1 Singer
      • Northland Capital Partners
      • piworld.co.uk
      • Proactive Investors
      • Progressive Equity Research
      • QuotedData
      • Radnor Capital Partners
      • Research Tree
      • SP Angel
      • Stockdale Securities
      • Trinity Delta
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Zeus Capital
    • Video/Audio Interviews
      • BRR Media
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • piworld.co.uk
      • Proactive Investors
      • Research Tree
  • Contact
  • Sign Up
  • Sign In